The ingredients of a successful biopharma collaboration

Collaboration is important along the entire spectrum and lifecycle of biopharma, and finding an effective partner is harder than it sounds.

By Michael Gibney • June 13, 2023

Yes, biopharma still has a reputation problem. These leaders are looking for solutions.

Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.

By Michael Gibney • June 8, 2023

Explore the Trendline➔

Commercialization, marketing and social media

As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical. 

By PharmaVoice staff

Woman of the Week: Marinus Pharmaceuticals’ Christy Shafer

The chief commercial officer shares how the company “beat the odds” to bring a rare disease drug to market.

By Taren Grom • June 7, 2023

Ranking reveals biopharma’s most innovative companies

IDEA Pharma’s 12th index finds that Pfizer and AstraZeneca reign supreme again.

By Taren Grom • June 7, 2023

BIO’s CEO digs into the hot-button issues facing the industry

Rachel King took the reins at BIO during a rocky time. Now, after steadying the ship, she’s brought the trade association’s focus back to the industry’s most pressing priorities.

By Alexandra Pecci • June 5, 2023

Janssen and Legend’s longtime collaboration lands a CAR-T win at ASCO

A partnership going on six years between the pharma giant and the Chinese biotech is showing that their CAR-T cell therapy for multiple myeloma is highly effective.

By Michael Gibney • June 5, 2023

A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

By Taren Grom • June 2, 2023

How Takeda finds the hottest new science to fuel its oncology work

Takeda's president of the global oncology business unit is always "scanning the horizon" for the partnerships that will drive the next big innovations.

By Michael Gibney • June 1, 2023

Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

By Taren Grom • May 31, 2023

The ‘superpowers’ pharma leaders should cultivate

Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

By Taren Grom • May 26, 2023

Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi

As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

By Taren Grom • May 24, 2023

How biopharma executives fight burnout

Pharma leaders share what they do to keep their teams from fizzling out.

By Taren Grom • May 19, 2023

What pharma can teach biotech about the life cycle management of a drug

Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.

By Dr. Stephen Dale and Kathleen Ford • May 18, 2023

Woman of the Week: Genentech’s Veronica Sandoval

How the Genentech diversity exec is using ‘three Ms’ to reduce health disparities and improve access for under-supported communities.

By Taren Grom • May 17, 2023

A day in the life of a pharma exec: Lyndra’s Patricia Hurter

How the CEO starts each day with a ride on one of her horses, reduces daily meetings and uses her network to get through crises like the SVB Bank collapse.

By Meagan Parrish • May 17, 2023

AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’

With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.

By Taren Grom • May 10, 2023

Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall

After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.

By Taren Grom • May 10, 2023

This ‘hot-blooded’ CEO is aiming to transform the way burn victims heal

Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.

By Alexandra Pecci • May 9, 2023

How Immunocore’s Bahija Jallal embraced the ‘a-ha’ moment of promising science

The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.

By Taren Grom • May 5, 2023

Navigating workforce challenges amid a turbulent biopharma market

A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.

By Karissa Waddick • May 4, 2023

A biopharma CEO opens up about executive salaries — and why he wants to change the status quo

With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

By Michael Gibney • May 4, 2023

Attracting up-and-coming talent in biotech

The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.

By Meagan Parrish • May 3, 2023

Woman of the Week: Jazz Pharmaceuticals’ Neena Patil

Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

By Taren Grom • May 3, 2023

From science to strategy, this exec is painting Genmab’s bigger picture into the next decade

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

By Michael Gibney • May 2, 2023

A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient

The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.

By Taren Grom • May 1, 2023